|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | |
| A61K 9/20 | |||
| A61K 9/50 | |||
| A61K 47/48 | |||
| A61K 31/357 |
| (11) | Number of the document | 1973528 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07870164.6 |
| Date of filing the European patent application | 2007-11-16 | |
| (97) | Date of publication of the European application | 2008-10-01 |
| (45) | Date of publication and mention of the grant of the patent | 2012-11-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/084961 |
| Date | 2007-11-16 |
| (87) | Number | WO 2008/061226 |
| Date | 2008-05-22 |
| (30) | Number | Date | Country code |
| 859502 P | 2006-11-17 | US |
| (72) |
LIANG, Likan, US
WANG, Hua, US
BHATT, Padmanabh P., US
VIEIRA, Michael L., US
|
| (73) |
Supernus Pharmaceuticals, Inc.,
1550 East Gude Drive, Rockville, MD 20850,
US
|
| (54) | SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE |
| SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE |